High frequency of altered HLA class I phenotypes in laryngeal carcinomas (Q73693806)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10773352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

High frequency of altered HLA class I phenotypes in laryngeal carcinomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10773352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

T Cabrera

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10773352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J Salinero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10773352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M A Fernandez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10773352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Garrido

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10773352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J Esquivias

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10773352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

F Garrido

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10773352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10773352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10773352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10773352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

499-506

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10773352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10773352%20AND%20SRC:MED&resulttype=core&format=json

Natural history of HLA expression during tumour development.

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Mechanisms of loss of HLA class I expression on colorectal tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

1 reference

7 January 2021

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Immunogenetic factors in HPV-associated cervical cancer: influence on disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

High frequency of altered HLA class I phenotypes in invasive breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Identification of the amino acid residues defining an intralocus determinant in the alpha 1 domain of HLA-A molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

HIV's evasion of the cellular immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Can the HLA phenotype be used as a prognostic factor in breast carcinomas?

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

Reduction of major histocompatibility complex class I antigens on invasive and high-grade transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

HLA and cancer: from research to clinical impact

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900097-5

7 January 2021

10.1016/S0198-8859(00)00097-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10773352%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference